Sparing of mdx extraocular muscles from dystrophic pathology is not attributable to normalized concentration or distribution of neuronal nitric oxide synthase

Neuromuscular Disorders

Volumn 8, Issue 1, 1998, Pages 22-29

  Wehling, Michelle ^a   Stull, James T ^b   McCabe, Timothy J ^b   Tidball, James G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Extraocular muscle; mdx mouse; Muscular dystrophy; Neuronal nitric oxide synthase; Skeletal muscle

Indexed keywords

DYSTROPHIN; MUSCLE PROTEIN; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOSOL; ENZYME BINDING; EXTRAOCULAR MUSCLE; MOUSE; MUSCLE CELL; MUSCULAR DYSTROPHY; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; SARCOLEMMA; STOICHIOMETRY; TIBIALIS ANTERIOR MUSCLE;

AGING; ANIMALS; CYTOSOL; DYSTROPHIN; DYSTROPHIN-ASSOCIATED PROTEINS; FEMALE; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, INBRED MDX; MUSCLE DEVELOPMENT; MUSCLE PROTEINS; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, ANIMAL; NITRIC OXIDE SYNTHASE; OCULOMOTOR MUSCLES; REFERENCE VALUES; SARCOLEMMA;

EID: 0032005566     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-8966(97)00136-3     Document Type: Article

References (45)

1. [1] Mendell JR, Sahenk Z, Prior TW. The childhood muscular dystrophies: diseases sharing a common pathogenesis of membrane instability. J Child Neurol 1995;10(2):150-159.
2. [2] Hoffman EP, Brown RH Jr, Kunkel LM. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 1987; 51:919-928.
3. [3] Gillis JM. Membrane abnormalities and Ca homeostasis in muscles of the mdx mouse, an animal model of the Duchenne muscular dystrophy: a review. Acta Physiol Scand 1996;156:397-406.
4. [4] Worton R. Muscular dystrophies: diseases of the dystrophin-glycoprotein complex. Science 1995;270:755-756.
5. [5] Ohlendieck K. Towards an understanding of the dystrophin-glycoprotein complex: linkage between the extracellular matrix and the membrane cytoskeleton in muscle fibers. Eur J Cell Biol 1996;69:1-10.
6. [6] Khurana TS, Prendergast RA, Alamaddine HS. et al. Absence of extraocular muscle pathology in Duchenne's muscular dystrophy: role for calcium homeostasis in extraocular muscle sparing. J Exp Med 1995;182:467-475.
7. [7] Hoffman EP, Morgan JE, Watkins SC, Partridge TA. Somatic reversion/suppression of the mouse mdx phenotype in vivo. J Neurol Sci 1990;99:9-25.
8. [8] Nicholson LVB, Davidson K, Johnson MA. et al. Immunoreactivity in patients with Xp21 muscular dystrophy. J Neurol Sci 1989;94:137-146.
9. [9] Thanh LT, Man N, Helliwell TR, Morris GE. Characterization of revenant muscle fibers in Duchenne muscular dystrophy, using exon-specific monoclonal antibodies against dystrophin. Am J Hum Genet 1995;56:725-731.
10. [10] Winnard AV, Mendell JR, Prior TW, Florence J, Burghes AHM. Frameshift deletions of exons 3-7 and revertant fibers in Duchenne muscular dystrophy: mechanisms of dystrophin production. Am J Hum Genet 1995;56:158-166.
11. [11] Hoffman EP, Gorospe JRM. The animal models of Duchenne muscular dystrophy: windows on the pathophysiological consequences of dystrophin deficiency. In: Mooseker MS, Morrow JS, editors. Current topics in membranes. Vol. 38. New York: Academic Press, 1991:113-154.
12. [12] Ohlendieck K, Matsumura K, Ionasescu VV. et al. Duchenne muscular dystrophy: deficiency of dystrophin-associated proteins in the sarcolemma. Neurology 1993;43:795-800.
13. [13] Jackson MJ, O'Farrell S. Free radicals and muscle damage. Br Med Bull 1993;49(3):630-641.
14. [14] Haycock JW, Jones P, Harris JB, Mantle D. Differential susceptibility of human skeletal muscle proteins to free radical induced oxidative damage: a histochemical, immunocytochemical and electron microscopical study in vitro. Acta Neuropathol 1996;92:331-340.
15. [15] Ragusa RJ, Chow CK, St Clair DK, Porter JD. Extraocular, limb, and diaphragm muscle group-specific antioxidant enzyme activity patterns in control and mdx mice. J Neurol Sci 1996;139:180-186.
16. [16] Jackson MJ, Jones DA, Edwards RHT. Techniques for studying free radical damage in muscular dystrophy. Med Biol 1984;62:135-138.
17. [17] Kar NC, Pearson CM. Catalase, superoxide dismutase, glutathione reductase and thiobarbituric acid-reactive products in normal and dystrophic human muscle. Clin Chim Acta 1979;94:277-280.
18. 2+ metabolism. Med Hypotheses 1989;29:187-193.
19. [19] Janssen YMW, Van Houten B, Borm PJA, Mossman BT. Cell and tissue responses to oxidative damage. Lab Invest 1993;69(3):261-273.
20. [20] Matkovics B, Gyurkovits K, Laszlo A, Szabo L. Altered SOD values in erythrocytes from children with Duchenne muscular dystrophy. In: Greenwald RA, Cohen G, editors. Oxy radicals and their scavenger systems. Vol. II. Amsterdam: Elsevier, 1983:411-415.
21. [21] Mechler F, Imre S, Dioszeghy P. Lipid peroxidation and superoxide dismutase activity in muscle and erythrocytes in Duchenne muscular dystrophy. J Neurol Sci 1984;63:279-283.
22. [22] Karpati G, Carpenter S, Prescott S. Small-caliber skeletal muscle fibers do not suffer necrosis in mdx mouse dystrophy. Muscle Nerve 1988;11:795-803.
23. [23] Kaminski HJ, Al-Hakim M, Leigh RJ, Katirji MB, Ruff RL. Extraocular muscles are spared in advanced muscular dystrophy. Ann Neurol 1992;32:586-588.
24. [24] Darley-Usmar V, Wiseman H, Halliwell B. Nitric oxide and oxygen radicals: a question of balance. FEBS Lett 1995;369:131-135.
25. [25] Snyder SH. More jobs for that molecule. Nature 1994;372:504-505.
26. [26] Cannon JG, Meydani SN, Fielding RA. et al. Acute phase response in exercise. II. Associations between vitamin E, cytokines, and muscle proteolysis. Am J Physiol 1991;260:R1235-R1240.
27. [27] Kanter MM, Nolle LA, Holloszy JO. Effects of an antioxidant vitamin mixture on lipid peroxidation at rest and postexercise. J Appl Physiol 1993;74:965-969.
28. [28] Viguie CA, Frei B, Shigenaga MK, Ames BN, Packer L, Brooks GA. Antioxidant status and indexes of oxidative stress during consecutive days of exercise. J Appl Physiol 1993;75:566-572.
29. [29] Nakane M, Schmidt HHHW, Pollock JS, Forstermann U, Murad F. Cloned human brain nitric oxide synthase is highly expressed in skeletal muscle. FEBS Lett 1993;316 (2):175-180.
30. [30] Kobzik L, Reid MB, Bredt DS, Stamler JS. Nitric oxide in skeletal muscle. Nature 1994;372:546-548.
31. [31] Silvagno F, Xia H, Bredt DS. Neuronal nitric oxide-synthase-μ, an alternatively spliced isoform expressed in differentiated skeletal muscle. J Biol Chem 1996;271 (19):11204-11208.
32. [32] Brenman JE, Chao DS, Xia H, Aldape K, Bredt DS. Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy. Cell 1995;82:743-752.
33. [33] Chang WJ, Iannaccone ST, Lau KS. et al. Neuronal nitric oxide synthase and dystrophin-deficient muscular dystrophy. Proc Natl Acad Sci USA 1996;93:9142-9147.
34. [34] Gath I, Gloss EI, Godtel-Armbrust U. et al. Inducible NO synthase II and neuronal NO synthase I are constitutively expressed in different structures of guinea pig skeletal muscle: implications for contractile function. FASEB J 1996;10:1614-1620.
35. [35] Bredt DS. Targeting nitric oxide to its targets. Proc Soc Exp Biol Med 1996;211:41-48.
36. [36] Grozdanovic Z, Gosztonyi G, Gossrau R. Nitric oxide synthase I (NOS-1) is deficient in the sarcolemma of striated muscle fibers in patients with Duchenne muscular dystrophy, suggesting an association with dystrophin. Acta Histochem 1996;98:61-69.
37. [37] Chao DS, Hwang PM, Huang F, Bredt DS. Localization of neuronal nitric oxide synthase. In: Packer L, editor. Methods in enzymology. Vol. 268. San Diego, CA: Academic Press, 1996:488-496.
38. [38] Brenman JE, Chao DS, Gee SH. et al. Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and α1-syntrophin mediated by PDZ domains. Cell 1996;84:757-767.
39. [39] DiMario JX, Uzman A, Strohman RC. Fiber regeneration is not persistent in dystrophic (mdx) mouse skeletal muscle. Dev Biol 1991;148:314-321.
40. 4. Nature (Lond) 1970;227:680-685.
41. [41] Burnette WN. 'Western blotting': electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographie detection with antibody and radio-iodinated protein A. Anal Biochem 1981;112:195-203.
42. [42] Miles AM, Bohle DS, Glassbrenner PA, Hansert B, Wink DA, Grisham MB. Modulation of superoxide-dependent oxidation and hydroxylation reactions by nitric oxide. J Biol Chem 1996;271(1): 40-47.
43. [43] Rotundo RL, Gomez AM. Nucleus-specific translation and assembly of acetylcholinesterase in multinucleated muscle cells. J Cell Biol 1990;110:715-719.
44. [44] Porter JD, Baker RS. Muscles of a different 'color': the unusual properties of the extraocular muscles may predispose or protect them in neurogenic and myogenic disease. Neurology 1996;46:30-37.
45. [45] Spencer MJ, Croall DE, Tidball JG. Calpains are activated in necrotic fibers from mdx dystrophic mice. J Biol Chem 1995;270 (18):10909-10914.